Kane Biotech Inc is a biotechnology company engaged in the development of products to prevent and disperse biofilms.In September 2020, Kane Biotech Inc agreed with Animalcare Group PLC to form STEM Animal Health Inc to treat biofilm-related ailments in animals.In August 2023, Kane Biotech Inc intented to undertake a non-brokered private placement offering of up to 6,250,000 units of the Company at a price of $0.08 per Unit for gross proceeds of up to $500,000.In December 2022, Kane Biotech Inc announces that it has reached an agreement to obtain loans of $2,000,000 from two lenders that will bear interest at 12% per annum.In March 2022, Kane Biotech Inc announced its intention to undertake a non-brokered private placement offering of 10,000,000 common shares at $0.10 per share to share $1,000,000. In May 2022, the offering was completed.In May 2020, the company announced that its shares of the corporation had been reapproved for and would recommenced tradi